Retained Products. Synthetic shall be permitted to continue the clinical development and Commercialization in the Field of any Synthetic Product that, at the time of termination, satisfies at least one of the following criteria (a “Retained Product”):
Appears in 3 contracts
Samples: Exclusive Channel Collaboration Agreement (Intrexon Corp), Exclusive Channel Collaboration Agreement (Intrexon Corp), Collaboration Agreement (Synthetic Biologics, Inc.)
Retained Products. Synthetic shall be permitted to continue the clinical development and Commercialization in the Field of any Synthetic Collaboration Product that, at the time of termination, satisfies at least one of the following criteria (a “Retained Product”):
Appears in 1 contract
Samples: Exclusive Channel Collaboration Agreement (Synthetic Biologics, Inc.)
